• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Digital Tool for Inflammatory Bowel Disease Therapy Demonstrates Good Usability in Testing

by
November 20, 2026
in Health, Technology
Reading Time: 3 mins read
0
Digital Tool for Inflammatory Bowel Disease Therapy Demonstrates Good Usability in Testing

Digital Tool for Inflammatory Bowel Disease Therapy Demonstrates Good Usability in Testing

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A newly developed digital patient decision aid designed to support treatment choices in inflammatory bowel disease demonstrated good usability and acceptability during alpha testing with patients and clinicians, according to findings published in BMC Medical Informatics and Decision Making. The web-based application, designated I(BD) SELECT, was systematically developed to assist individuals facing complex, preference-sensitive choices regarding their long-term disease management, specifically regarding the initiation or switching of advanced therapies.

The study focused on addressing decisional needs within the Belgian healthcare context, where the expanding availability of therapeutic options has made long-term inflammatory bowel disease management increasingly preference-sensitive. Although professional recommendations advocate for shared decision making to align clinical treatment plans with personal patient values, practical tools designed to facilitate shared decision making in this clinical domain remain limited.

To construct the decision aid, the research team followed a multi-phase, user-centered design process aligned with the International Patient Decision Aid Standards guidance. During the initial development phase, researchers explored decisional requirements by conducting semi-structured interviews with 15 patients living with inflammatory bowel disease and 23 practicing healthcare professionals to determine the essential scope, structure, and clinical content of the tool.

Findings from the initial needs assessment identified the initiation of advanced therapies and switching between them as central preference-sensitive decisions, which subsequently established the operational scope of the platform. Based on this evidence, the team developed an evidence-informed digital prototype that incorporated a discrete choice experiment intended to serve as a structured values clarification exercise for users.

The resulting web-based decision aid delivers tailored treatment information and generates an individualized preference summary derived from patient responses to the discrete choice experiment. To assess its functional performance, investigators conducted iterative alpha testing with a separate cohort comprising 17 patients and 18 healthcare professionals. These evaluators engaged in think-aloud evaluation sessions, semi-structured interviews, and standardized usability questionnaires, yielding an overall mean System Usability Scale score of 78.9 out of 100.

Participants indicated that they valued the balanced presentation of information alongside the personalized preference summaries, noting that the system helped them reflect on their treatment preferences and could assist in preparing for clinical consultations. Feedback gathered during testing highlighted specific areas for refinement, which focused primarily on user navigation and textual wording. The authors noted that these qualitative and quantitative suggestions were incorporated iteratively into the prototype’s revised interface.

Most participating patients and healthcare professionals indicated a clear willingness to use the digital decision aid within routine clinical practice. The authors concluded that combining tailored clinical information with structured preference elicitation offers a promising method to enhance shared decision making in inflammatory bowel disease care, noting that active field testing is currently underway to evaluate the tool’s practical feasibility, clinical effectiveness, and broader impact in routine healthcare environments.

The structured multi-phase development strategy adhered to International Patient Decision Aid Standards guidance to ensure rigorous creation of the digital tool. By pairing tailored treatment information with a discrete choice experiment, the prototype operationalized values clarification to help users consider their personal priorities. Qualitative and quantitative findings gathered from think-aloud sessions, usability questionnaires, and semi-structured interviews continuously guided iterative refinements, allowing developers to improve textual wording and interface navigation based on direct user input.

Although alpha testing confirmed that the decision aid is usable and acceptable among both patients and healthcare professionals, comprehensive clinical evaluation remains an active next phase. Investigators are currently conducting field testing to evaluate the platform’s clinical effectiveness, practical feasibility, and overall impact within routine healthcare settings. This ongoing research will determine how successfully structured preference elicitation supports shared decision making during actual clinical practice.

Subject of Research: Digital patient decision aid usability for inflammatory bowel disease treatment decisions

Article Title: Development and usability testing of I(BD) SELECT: a digital patient decision aid for advanced therapy decisions in inflammatory bowel disease

Article References: Schoefs, E., Vandebroek, M., Ferrante, M., Verstockt, B., Sabino, J., Debrun, L., Lambrechts, T., Michiels, L., Lenaerts, S., Van Aerschot, A., Van Audenhove, C., Straetemans, N., Vermeire, S., & Huys, I. (2026). Development and usability testing of I(BD) SELECT: a digital patient decision aid for advanced therapy decisions in inflammatory bowel disease. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-026-03939-7

Image Credits: AI Generated

DOI: 10.1186/s12911-026-03939-7

Keywords: inflammatory bowel disease, patient decision aid, shared decision making, advanced therapies, discrete choice experiment, System Usability Scale, alpha testing, values clarification, think-aloud sessions, usability testing, IPDAS standards, preference-sensitive decisions, Belgian healthcare, digital health prototype, treatment decision support, clinical consultation preparation

News Source: Denise Maddox. (November 20, 2026). Digital Tool for Inflammatory Bowel Disease Therapy Demonstrates Good Usability in Testing. Scienmag.

Tags: advanced therapiesAlpha TestingBelgian healthcareclinical consultation preparationdigital health prototypediscrete choice experimentinflammatory bowel diseaseIPDAS standardspatient decision aidpreference-sensitive decisionsshared decision-makingSystem Usability Scalethink-aloud sessionstreatment decision supportusability testingvalues clarification
Share12Tweet7Share2ShareShareShare1

Related Posts

Subcutaneous IgPro20 Linked to Reduced Acute Care in US CIDP Patients

Subcutaneous IgPro20 Linked to Reduced Acute Care in US CIDP Patients

November 20, 2026
Researchers Propose Neuro-EDS Framework for Neurological Subgroups in Hypermobile Disorders

Researchers Propose Neuro-EDS Framework for Neurological Subgroups in Hypermobile Disorders

November 20, 2026

Systematic Review Traces Drone Evolution from Military Reconnaissance to Biomimetic Wings

November 20, 2026

Minimally Invasive Surgery Shows Lower Short-Term Morbidity in Advanced Colon Cancer

November 20, 2026

POPULAR NEWS

  • Review Evaluates Integrins as Potential Mediators and Targets in Metabolic Disorders

    Review Evaluates Integrins as Potential Mediators and Targets in Metabolic Disorders

    29 shares
    Share 12 Tweet 7
  • Tutorial Review Synthesizes Evolution and Applications of Remote Sensing Multimodal Models

    29 shares
    Share 12 Tweet 7
  • Blood MicroRNA Level Predicts Late Cytomegalovirus Infection in High-Risk Kidney Recipients

    29 shares
    Share 12 Tweet 7
  • Insurance Deductions Impact Up to Half of Hospital Records in Iranian Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Subcutaneous IgPro20 Linked to Reduced Acute Care in US CIDP Patients

Researchers Propose Neuro-EDS Framework for Neurological Subgroups in Hypermobile Disorders

Systematic Review Traces Drone Evolution from Military Reconnaissance to Biomimetic Wings

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.